Am J Transplant, Volume 21, Suppl 3 Archives - Page 94 of 139 - ATC Abstracts

2021 American Transplant Congress
Tolerability of De Novo and Conversion Belatacept Regimens in Kidney Transplantation
T. Le¹, J. Shoji², J. Phillips¹, D. Quan¹
¹Pharmaceutical Services, UCSF Medical Center, San Francisco, CA, ²Transplant Nephrology, UCSF Medical Center, San Francisco, CA
*Purpose: Belatacept, a selective T lymphocyte co-stimulation blocker, has been shown to be a safe and effective maintenance therapy for immunosuppression. We investigated the long-term…
2021 American Transplant Congress
The Impact of Diabetes on Young Transplant Recipients: An American Perspective
J. M. Loera, S. C. Barrett, T. S. Zhang, A. A. Awan, B. V. Murthy, R. T. Cotton, C. A. O'Mahany, N. T. Galvan, J. A. Goss, A. A. Rana
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX
*Purpose: Our study aims to demonstrate the impact of diabetes, types I and II, on American young adults (18-40 years old) requiring kidney transplantation.*Methods: Using…
2021 American Transplant Congress
Alterations in Mineral Metabolism of Living Kidney Donors: Prospective Observational Study
H. Lee¹, E. Ko¹, H. Cho², C. Yang¹, B. Chung¹
¹Division of Nephrology, Department of Internal Medicine, Seoul St. Mary’s Hospital, Seoul, Korea, Republic of, ²Department of Urology, Seoul St. Mary’s Hospital, Seoul, Korea, Republic of
*Purpose: The aim of this study is to investigate whether reduction in glomerular filtration rate (GFR) after kidney donation causes mineral metabolism alterations, and also…
2021 American Transplant Congress
Is There a Role for Pre-Operative Angiographic Kidney Embolization Prior to Allograft Nephrectomy?
M. Jacobs¹, R. Stratta¹, D. Harriman², A. Farney¹, J. Rogers¹, G. Orlando¹, A. Reeves-Daniel¹, C. Jay¹
¹Wake Forest Baptist Health, Winston Salem, NC, ²University of British Columbia, Vancouver, BC, Canada
*Purpose: To determine if morbidity associated with allograft nephrectomy (AN) of a failed or diseased kidney transplant (KT) is improved by pre-operative angiographic kidney embolization…
2021 American Transplant Congress
The Differential Impact of Size Mismatch in Live versus Deceased Donor Kidney Transplant
A. J. Vinson¹, T. Skinner², B. Kiberd³, D. Clark¹, K. Tennankore¹
¹Division of Nephrology, Department of Medicine, Nova Scotia Health Authority, Halifax, NS, Canada, ²Department of Urology, Nova Scotia Health Authority, Halifax, NS, Canada, ³Dalhousie University, Halifax, NS, Canada
*Purpose: The risk of significant weight mismatch between donors and recipients (D-R) undergoing living donor kidney transplant (LDKT) is not well established. Further, how this…
2021 American Transplant Congress
Development Following Pediatric Kidney Transplantation
L. Pape, J. Prüfe
Pediatrics II, University Hospital of Essen, Essen, Germany
*Purpose: Kidney transplantation for children suffering CKD5 has been established in Germany approximately 50 years ago. While in the early decades the focus was merely…
2021 American Transplant Congress
Utility of Donor-Derived Cell Free DNA for Detecting ABMR in Patients With AT1R Antibodies
S. Kant¹, D. Kumar², I. Moinuddin², T. Alhamad³, M. Haris³, J. Gray⁴, B. Dale⁴, M. Bettinotti¹, D. C. Brennan¹
¹Johns Hopkins University School of Medicine, Baltimore, MD, ²VCU, Richmond, VA, ³Wash Univ, St. Louis, MO, ⁴CareDx, Brisbane, CA
*Purpose: The presence of angiotensin II type 1 receptor (AT1R) antibodies is associated with non-HLA active antibody mediated rejection (ABMR). The frequent co-existence of negative…
2021 American Transplant Congress
Psmp is Discriminative for Chronic Active Antibody-Mediated Rejection and Predicts Graft Risk After Kidney Transplantation
Y. Fu, P. Zhan
Tianjin First Central Hospital, Tianjin, China
*Purpose: Chronic active antibody-mediated rejection (c-aABMR) is an intermediate process in the development of chronic antibody-mediated rejection (c-ABMR), a key problem in the long-term failure…
2021 American Transplant Congress
Association of Donor-Derived Cell-Free DNA with Severity of Interstitial Fibrosis and Cortical Atrophy Lesions Following Kidney Transplantation
L. Bu¹, E. Stites², V. Bowers³, T. Alhamad⁴, J. S. Bromberg⁵, G. Gupta⁶, I. Moinuddin⁶, S. Ghosh⁷, W. Tian⁷, A. Pai⁸, S. Anand⁹
¹University of Minnesota, Minneapolis, MN, ²University of Colorado, Aurora, CO, ³Tampa General Hospital, Tampa, FL, ⁴Washington University in St. Louis, St. Louis, MO, ⁵University of Maryland School of Medicine, Baltimore, MD, ⁶Virginia Commonwealth University, Richmond, VA, ⁷CareDx, Brisbane, CA, ⁸University of Texas McGovern Medical School, Houston, TX, ⁹Intermountain Medical Center, Murray, UT
*Purpose: The most common cause of kidney transplant (KT) failure is the poorly characterized histopathologic entity “interstitial fibrosis and tubular atrophy” (IFTA). There are no…
2021 American Transplant Congress
Subjective Cognition Among Liver Transplant Recipients
D. Ko¹, M. S. Dietrich², K. A. Gifford³, S. H. Ridner²
¹School of Nursing, Northeastern University, Boston, MA, ²School of Nursing, Vanderbilt University, Nashville, TN, ³Department of Neurology, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Regular assessment of cognition is highly suggested to facilitate the early detection and treatment of cognitive impairment in the liver transplant (LT) population. While…